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ABSTRACT: The congenital heart care community faces a myriad of public health issues that act as barriers toward optimum
patient outcomes. In this article, we attempt to define advocacy and policy initiatives meant to spotlight and potentially address these challenges. Issues are organized into the following 3 key facets of our community: patient population, health care
delivery, and workforce. We discuss the social determinants of health and health care disparities that affect patients in the
community that require the attention of policy makers. Furthermore, we highlight the many needs of the growing adults with
congenital heart disease and those with comorbidities, highlighting concerns regarding the inequities in access to cardiac
care and the need for multidisciplinary care. We also recognize the problems of transparency in outcomes reporting and the
promising application of telehealth. Finally, we highlight the training of providers, measures of productivity, diversity in the
workforce, and the importance of patient–family centered organizations in advocating for patients. Although all of these issues
remain relevant to many subspecialties in medicine, this article attempts to illustrate the unique needs of this population and
highlight ways in which to work together to address important opportunities for change in the cardiac care community and
beyond. This article provides a framework for policy and advocacy efforts for the next decade.
Key Words: advocacy ■ congenital heart disease ■ health care disparities ■ health care policy ■ health care workforce ■ value-based
health care

T

he pediatric and adult congenital heart care communities face broad public health issues, including disparities in care, continuous increases in
health care costs, and challenges with transparency
in outcomes.1-3 We recognize the importance of distinguishing congenital heart disease (CHD) within larger
arenas of discussion, including through our collaborations with various pediatric and adult organizations
and societies including the American Academy of
Pediatrics, the American College of Cardiology, the
American Heart Association, the Joint Council on
Congenital Heart Disease, and the Congenital Heart
Public Health Consortium. In this article, we attempt

to convene agendas on advocacy and policy issues
for CHD, many of which have been identified and highlighted as a result of the COVID-19 pandemic (Figure).
CHD is the most common cause of birth defects
and is one of the leading causes of morbidity, mortality,
and resource use for congenital defects in the United
States.2,4 The disease spectrum is heterogeneous and
is managed from fetus into adulthood with varied outcomes at different stages for individual patients. It is
important to advocate for the needs of this population
to achieve the best health care outcomes while optimizing resources. Contemporary conversations regarding
congenital heart care focus on caring for the congenital
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Nonstandard Abbreviations and Acronyms
ACHD
CMS
RVU
SDOH
STS
wRVU

adult congenital heart disease
Center for Medicare and Medicaid
Services
relative value unit
social determinants of health
Society of Thoracic Surgeons
work relative value unit
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heart population into adulthood and assuring a smooth
transition into adult care, consolidation and regionalization of procedural and surgical care, and the financial
constraints of delivering multidisciplinary care to a highly
complex population. The COVID-19 pandemic exposed
many preexisting issues, especially those regarding
diversity and disparities, equity in access to care, and
questions of medical necessity and resource use. The
pandemic prompted a sense of urgency regarding congenital cardiac community care and the need for advocacy for this vulnerable population.
Caring for children with CHD is resource intensive.
Admissions for CHD cost an estimated $5.6 billion
annually. This comprises 15% of costs for all inpatient pediatric care despite accounting for only 3.7%
of all pediatric admissions.5,6 Nationally, 120 pediatric cardiac programs perform >40 000 surgical and
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catheter-based interventions annually with significant
variability in volume, outcomes, and costs at each
hospital.7
During the past several years, stakeholder groups including professional organizations, patient/family organizations, and individuals have achieved key legislation
and regulations that benefit the care and management
of patients with CHD and their families. In 2018, the
Congenital Heart Futures Reauthorization Act of 2017
(H.R. 1222/S. 477) was signed into law.8 This legislation
serves to enhance research and surveillance efforts at
the Centers for Disease Control and Prevention toward
the study of CHD and direct the National Institutes of
Health to report on their ongoing research efforts. The
Advancing Care for Exceptional Kids Act of 2019 was
signed into law9 in the same year as a component of
the Medicaid Services Investment and Accountability
Act of 2019 (H.R. 1839),10 which benefits preexisting
conditions such as CHD. This legislation aims to establish specially designed health homes for children
with medically complex conditions and is voluntary
for states, families, and providers. Furthermore, this
bill mandates data and quality measure reporting for
states and health homes, allows new payment models
that better align payment with best outcomes, and includes a national definition for children with medically
complex conditions including CHD.
Recent additional changes in care models and reimbursement have been catalyzed by the COVID-19

Figure 1. Infographic.
AAP indicates American Academy of Pediatrics; ACC, American College of Cardiology; AHA, American Heart Association; and CHD,
congenital heart disease.
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pandemic. In March 2020, the Center for Medicare and
Medicaid Services (CMS) announced new flexibility to
provide telehealth services to beneficiaries regardless
of originating site location. CMS issued a second final
interim rule in April 2020 that included several key measures, including expanded access to COVID-19 testing
and implementation of telehealth services requested
by the American College of Cardiology and others from
across the House of Medicine; the legislative and policy making body of the American Medical Association.
This increased payments for virtual visits to match
those for in-person office visits. These 2 simple modifications improved delivery of care and prompted
efficient and cost-effective models that will influence
health policy long after the pandemic has ended.
Value-based health care delivery prioritizes patient-
centered care, optimizes outcomes relative to cost,
and is distinct from programs designed to reduce
cost or improve outcome alone. Although value has
not been measured in the CHD population holistically,
methods to optimize outcomes and reduce cost have
been explored in specific CHD populations.11-15 The
congenital heart community has developed tools for
self-
examination and performance measures. Areas
for continued progress include organizing our delivery
“system,” efficiently sharing knowledge, and finding
better ways to assess and communicate our performance to effectively increase value.
Although the concept of self-assessment is crucial
to meaningful improvement, self-reporting is not entirely adequate. Alternatively, an externally organized,
disinterested peer-conducted auditing process would
seem preferable. With so-called Line Operations Safety
Assessments inspections, there is precedent for such
an approach in aviation, an industry with which congenital heart care is sometimes compared.16 There is
even precedent for such an approach in health care,
as anyone who has ever been through a visit by the
Joint Commission can attest. If restaurants are not allowed to inspect themselves, why do we think this is a
good idea for congenital heart programs?
Unfortunately, although improving, publicly available
outcome reports are imperfectly risk adjusted. Efforts
to effectively educate the public or policy makers regarding the meaning of data have not kept pace with
the release of information. Public reporting itself has
often been the singular goal at the expense of enabling
stakeholders to benefit from the information (patient
and family education, direction of patients to high-
performing centers, etc). The provision of information
to the public has often oversimplified complex data,
substituting clarity for accuracy. As an example, the
concept of ranking is inherently artificial. It is unreasonable to summarize the performance and capabilities of a congenital heart center with a single number,
conveying the erroneous concept that a center with
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a score of 89 is inferior to one with a score of 90.17
Improvements in the methodology of reporting and the
effectiveness of educational efforts are possible,18 and
the United Kingdom experience provides both cautionary and instructive lessons.19 Beyond public reporting,
outcomes assessment should become the basis for
systematic efforts at outcomes improvement.

THE POPULATION WE SERVE: THE
NEED FOR LIFELONG CARE
CHD is a lifelong disease with lifelong health care
needs. These patients represent a cohort with several
socioeconomic and systemic barriers preventing them
from receiving care and optimizing health. Access to
care can be improved by increased awareness of at-
risk rural and urban communities, expansion of management facilities, and arrangement of consistent and
stable follow-up (Table 1). Providing concentrated CHD
care at specialized pediatric cardiac centers for children and adolescents is imperative as well as transitioning the care of young adults to adult providers
with CHD expertise at specialized congenital cardiac
centers.20,21 Transitioning allows for advanced expertise and resources to manage complex patients.5,22,23
Table 1. 2020 Call to Action: Advocacy Efforts in the Next
Decade for Our Patients and Families
Accessibility
● Expand access for lifelong CHD care
○ Safeguard insurance coverage for children and young adults with
preexisting conditions
○ Continue expanded private health insurance benefits for older
children and consider additional expansion beyond age 25
● Develop models for improved portability of insurance benefits across
state lines
● Increase attention in rural contexts and at-risk urban communities for
efforts focusing on awareness, prevention, expansion of emergency
management, and follow-up care
● Lifelong insurance for patients with CHD
● CHD and ACHD centers
Funding
● Improve Medicaid funding by revisiting federal dollars as distributed
to states
● Expand Medicaid for vulnerable populations including those with
CHD
● Develop programs to advocate for Medicare parity within individual
states with the goal of increased/appropriate reimbursement for
services provided to Medicaid patients
● Address disparities created by balanced billing reform
● Research dollars: the Congenital Heart Futures Reauthorization Act,
CDC, NIH, AHRQ and so on
Issues related to the patients
● Address/assess health care disparities including consistency in care
and resources available for minority populations
● Secure advances that improve transition to adult care
● Expand awareness of comorbidities including neurodevelopmental
and psychosocial health
● Empowerment of patients and families through engagement of
patients and families and patient/parent-led organizations
ACHD indicates adult congenital heart disease; AHRQ, Agency for Healthcare
Research and Quality; CDC, Centers for Disease Control and Prevention; CHD,
congenital heart disease; and NIH, National Institutes of Health.
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Social determinants of health as well as institutional,
financial, and neurocognitive factors have been identified as barriers to the successful transfer to adult congenital heart disease (ACHD) care.5
With increasing numbers of individuals with CHD
surviving into adulthood, assuring access to high-
quality inpatient and outpatient ACHD care is critical
(Table 1). However, specialized centers are not available in all states. Patients often travel long distances for
clinic visits24 and incur significant expenses associated
with travel, accommodation, meals, child care, and so
on.25 Management of CHD in vulnerable ethnic groups
is even more challenging. Studies have demonstrated
that the quality of care at primary care locations is suboptimal, with fewer health resources, including fewer
diagnostic imaging centers and offices for physicians,
lesser diversity of physicians, and limited mental health
providers, dentists, and other health practitioners.26,27
To ensure that patients with CHD get adequate and
equal access to lifelong health care, legislative support is required. The focus should be toward effective
collaboration between the health care providers and
insurance providers to ensure that patients with coexisting conditions are able to receive insurance and also
facilitate expansion of insurance coverage to those
aged >25 years (Table 1).
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Health Care Disparities and Social
Determinants of Health
Longstanding systemic inequities (including historical systemic racism, institutional racism, implicit bias,
among others) have resulted in differences in social determinants of health (SDOH) and delivery of care that has
disproportionately affected communities of color. These
inequities became very apparent in the COVID-19 era.
To address quality and access to care, as well as health
care delivery, policies must balance those differences in
social determinants of health and systemic racism that
exist and contribute to disparities in outcomes for CHD
throughout the lifespan. Policies that seek to improve
outcomes in pediatric CHD and ACHD care are critical for populations most profoundly affected by these
disparities. These populations must be incorporated
into the value-based care delivery model if such populations are to be appropriately served and not excluded.
SDOH impact nearly all CHD and ACHD outcomes.28
Infants born to women in low-income and lower education neighborhoods have higher odds of having CHD.29
Maternal education and insurance status explains 33%
and 27% of the relationship between race or ethnicity
and poor outcome at 1 year of life.30 In-hospital postoperative mortality rates are highest among Hispanic
patients (3.9%) and lowest among non-
Hispanic
White patients (2.8%).31 Furthermore, mortality rates in
CHD persist among non-Hispanic Black patients and
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Hispanic patients during the lifespan compared with
non-Hispanic White patients.30,32 In addition to SDOH,
location of care and delivery of care in hospitals with
higher reported mortality rates, lower rates of prenatal
diagnosis,33 implicit bias, and other such factors may
further explain some of these racial or ethnic differences in outcomes. Accounting for SDOH, exposing institutional and implicit biases and diversifying workforce
composition for the delivery of outpatient and hospital-
based services can all be part of the larger solution to
improve disparities in outcomes. Much can be learned
from the efforts of other groups and from a deeper understanding of existing disparities.26,27,34 The development of a diverse workforce, enhanced access to adult
congenital providers, and expansion of easy access to
translation services for non-English-speaking patients
are all critical to improving outcomes.27 Therefore, policies that specifically address biases, SDOH, and resultant health disparities in the pediatric CHD and ACHD
populations are lacking and necessary.34,35 Disparities
may further be minimized by having balanced billing reforms (Table 1).

Insurance
Limitations in access to care are influenced by insurance coverage and geography.36 Among children and
young adults with CHD, disparities may be further exacerbated by insurance coverage limitations given the
presence of preexisting conditions. Historically, patients with ACHD have had a more difficult time obtaining health insurance.37,38 With uninsured rates among
children in the United States ranging from 3% to 5%,
an uninsured child is associated with 2 to 3 times the
mortality risk after surgical repair than their insured
peers.36,39 Sanders et al found that the percentage of
uninsured among infants varied significantly by race
and ethnicity: 11% of Asian infants, 16% of White infants, 17% of Black infants, 29.5% of Native American
infants, and 29% of mixed-race infants were not insured.40 Racial disparities in health provisions and
insurance coverage influence early and long-term outcomes with higher mortality rates seen in Black and
Hispanic patients following cardiac surgery. This is
potentially influenced by geographical factors as this
population may be referred for care in hospitals that
have low surgical volumes and high mortality rates regardless of race.41
Policies to protect diverse communities including not allowing insurance companies to discriminate
based on preexisting conditions or lifetime insurance
caps are critical to reducing racial/ethnic disparities
throughout the lifespan.42 The Affordable Care Act43
has provided major advantages to patients with ACHD
as they now have the same rate of public and private
insurance as their age-
matched cohort.38,44 The insurance through Affordable Care Act, however, is not
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accepted by all hospitals, adding further challenges
to the delivery of care for these patients. Even publicly and privately insured children or adults may have
irregular care or complete loss of care. Changing insurance plans (whether attributed to changes in public
insurance or parental employment) may necessitate
changing medical teams or lead to gaps in care, likely
altering outcomes.45 Patients with ACHD with functional impairments find applying for Supplemental
Security Income disability benefits unclear and challenging. There are very few specific diagnosis codes,
such as cyanosis at rest or with activity, that qualify
for Supplemental Security Income, thus many patients
with ACHD who have other reasons for activity limitations are excluded. Providing insurance to patients with
ACHD despite preexisting conditions and improved
definitions for obtaining Supplemental Security Income
would facilitate health care delivery and quality of life
for this population (Table 1).

Comorbidities

Downloaded from http://ahajournals.org by on December 3, 2021

Poor neurodevelopment is a sequela seen in some
patients with CHD and is associated with lower academic achievement, abnormalities in speech, and
behavioral challenges in childhood.46 These may limit
educational opportunities and achievement and lead
to decreased employability as an adult.37 Access to
high-
quality coordinated care and early intervention
may identify any limitations early and provide not only
opportunities for rehabilitation but also provide realistic
educational and career goals to the patient and family. However, across the United States there are limited
centers with combined cardiac and neurodevelopmental clinics, making accessibility a challenge.47 In
addition, although neurodevelopmental interventions
exist in pediatric care, these are further scant in adolescent and adult care, and therefore efforts need to
be put forth to address these deficiencies.48 The pediatric cardiologists should work in close association
with pediatric neurologists and developmental specialists to ensure that patients receive collaborative care.
This can be achieved by having established combined
cardiac–neurodevelopmental clinics or having an efficient referral system to prevent any delays in intervention. Patients and their families should be adequately
counseled about these comorbidities and their impact
(Table 1). In addition, educators and school systems
should be incorporated to ensure that individuals’ cognitive and physical growth can be optimized.
Improved survival of patients with CHD has led to
increased recognition and attention to extracardiac
comorbidities.49 These patients are at an increased
risk of developing diseases affecting multiple systems
such as liver, renal, and lung that require multidisciplinary care.50 Access to adult subspecialty medical
care is often challenging with patients struggling to find
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providers who accept their medical insurance. There
are specialized gynecologic and contraceptive requirements for patients with ACHD. Women of childbearing
age with ACHD may have added risks of morbidity and
mortality because of the effect of pregnancy-related
hemodynamic changes on the heart. This includes
complications of arrhythmias, heart failure, thrombosis, preterm delivery, and still birth.51 Because there are
specific gynecological and obstetric needs for such patients, collaboration with an ACHD specialist is imperative.51 These women should be evaluated by ACHD
specialists before conception so that high-risk women
can be identified and can be counseled for appropriate
management of complications should they arise. One
other area of poor accessibility and use is dental care.
There is overall poor awareness of the importance of
dental hygiene in CHD and ACHD, with 1 survey showing that 38% did not know dental hygiene had any correlation with heart disease.52 Barriers for dental care
include dental anxiety as well as cost.53 Pediatricians
and pediatric cardiologists should regularly convey
the importance of dental hygiene for these patients at
every visit and should have established dental partners
to ensure continuity of care. In addition, insurance coverage specific to dental needs should be provided to
these patients with minimal deductibles or copayment
so patients can use dental care with ease.
Psychological health issues, including anxiety, depression, and attention-
deficit/hyperactivity disorder,
are commonly associated with CHD, regardless of age
and severity. Mental illness is associated with reduced
quality of life and even premature mortality.54 However,
adequate psychological treatment and patient education is rare with limited access. Racial differences
are seen in the diagnosis and treatment for psychological health.55 In the long run, these limitations lead
to repeated school absences, resulting in lower educational levels and decreased employment.56,57 Policy
makers, therefore, need to ensure sufficient access to
high-quality mental health services despite the ethnicity of the patient and should have a particular focus
toward those of lower socioeconomic status who may
have other underlying stressors, such as systemic inequities, racism, and stigma surrounding anxiety and
depression, which may result in a lower willingness or
ability to seek care or self-report58,59 (Table 1).

DELIVERY OF HEALTH CARE
SERVICES
Portability
Health care policy, including the expansion of Medicaid
coverage, may overcome geographic and racial differences in insurance coverage and lessen the divide
between uninsured and insured infants.40 This may be
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achieved by improving Medicaid funding by revisiting
federal dollars as distributed to states (Table 1). The
pediatric cardiac community should actively advocate
for these patients, as they are vulnerable and are often
neglected during policy making. In addition, specific
initiatives should be made and programs should be
established that would advocate for Medicaid parity
with the goal to increase reimbursement for the services used. This would provide improved access to
quality care for children with CHD in all ethnic groups
(Table 1). However, not all studies have found that
federally supported expansions of health care eliminate all health disparities.36 Widening gaps in coverage have been identified based on different ethnicities
and among noncitizens, those speaking English as
a second language, those without a college degree,
and in those in families earning <300% of the federal
poverty level.36 Reimbursement from CMS through
state-
funded Medicaid programs for children and
Medicare for ACHD has remained poor. Only recently,
in March 2020, specialists for ACHD were finally recognized separately from general adult cardiologists for
their specific skills and care provided to their unique
patients by CMS through the use of a new specialty
code.23

Telehealth
Downloaded from http://ahajournals.org by on December 3, 2021

An important development during COVID-19 included
expanded use of telemedicine by many practitioners as the risks of leaving a safer home environment
were weighed against the benefits of in-person office
visits. Legislative changes resulting in significant payment increases for telemedicine delivery of care have
allowed practitioners to interact with patients more efficiently, preventing hospitalization and potentially decreasing the need for more frequent testing. Before
April 2020, telehealth had been available to seniors in
Original Medicare who lived in rural areas but was limited to specific services.60 Temporary policy changes
in telehealth during the COVID-19 pandemic allowed
patients to remain in their homes and receive care remotely and even across state lines. This model allows
care for both established and new patients alike. Visits
using both video and audio as well as audio only, in
many cases, are billed for the same value as in-person
visits.61,62 These provisions through the final rule that
expand telehealth coverage are temporary, yet congenital cardiologist and ACHD specialists praise the
potential benefits of continuing this coverage for the
patient population even beyond the COVID-19 pandemic. Because of the clustering of congenital cardiology specialists across a few cities in the United
States, many pediatric and adult congenital patients
have to travel hours or across state lines for routine
follow-up cardiac care. Yet, with continued expanded
coverage for telehealth visits and reimbursement
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equivalent to in-person visits, the burden of access
to health care and traveling long distances would be
ameliorated. However, telehealth consultation may add
to health care disparities and negatively affect the following populations: those belonging to lower socioeconomic backgrounds or living in rural areas, those
with lower health literacy, those with limited access
to technology, those with extremes of ages; children
and elderly, and those belonging to vulnerable ethnic
groups. Therefore, policy makers need to establish
systems that may allow equitable telehealth services to
all populations63,64 (Table 2). Careful evaluation of the
socioeconomic status and geographical feasibility of
patients and their families should be done in addition
to a patient’s clinical condition to decide whether the
patient may be evaluated in person or remotely.
Delivery of care in the ambulatory arena must remain agile, and the expanded use of telemedicine
during the COVID-19 pandemic demonstrates how
different practice models, funded appropriately, may
extend care and improve efficiency. Limitations in
care delivery related to prior authorization burden remains a significant concern for both ambulatory and
inpatient services. Finally, transparency in reporting
results will drive continued improvement in outcomes
if it is appropriately managed in the coming decade
(Table 2).

Authorization Process
Prior authorization requirements have been developed
by many payers with a goal to reduce practice variation and reduce overall costs. In the middle of a hospitalization or before leaving the hospital, use of these
services sometimes requires approval from the payer
before an appointment, test, or procedure is scheduled or a medication is prescribed. Unfortunately, the
prior authorization process often becomes very inefficient related to the amount of time required by the
Table 2. 2020 Call to Action: Advocacy Efforts in the Next
Decade That Influence Delivery of Services
● Reform/improve the prior authorization process: specific to
CHD, peer-to-peer process to be only performed by congenital
cardiologist, not be held accountable to adult guidelines
● Legislative for patient empowerment to have access to data
● Develop/expand platforms to facilitate transparency of data on
outcomes from all institutions
● Developing a CHD dashboard with outcomes that are accessible to
parents
● Develop mandated universal registries and databases that are
funded by the legislative process
● Develop a fully integrated universal database
● Development of centers of excellence for CHD
● Extend/enhance reforms initiated during the coronavirus pandemic
including telehealth programs
● Establish/define parameters for “value” in the care of patients with
CHD
● Use metrics to assess quality of life in CHD
CHD indicates congenital heart disease.
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practitioner and their colleagues to process the requests and address the appeals. Many practices have
had to designate ≥1 individuals whose sole job is to
apply for prior authorizations, increasing costs of the
practice. Many authorizations may take days to weeks
to process, delaying care and necessary treatment.
Prior authorizations often result in peer-to-peer conversations with physicians who are not familiar with
CHD; therefore, these time-
consuming and inconvenient conversations are actually peer-
to-
nonpeer
conversations. Finally, the prior authorization process
is meant to focus on indicated treatments and testing for a particular patient; this becomes difficult when
faced with a very heterogeneous cohort that lacks
large studies with backing of evidence. The “Patient
over Paperwork” initiative was created in CMS by The
Office of Burden Reduction and Health Informatics in
2017. This office showcased the continued efforts by
CMS during the COVID-19 pandemic to help reduce
burdens placed on health care providers. The approach of “Patient over Paperwork” should therefore
be adopted by health care systems to ensure that patients’ diseases are appropriately managed without
unnecessary delays or added costs (Table 2).

Inpatient Services
Downloaded from http://ahajournals.org by on December 3, 2021

For many practices, hospital-based services, including cardiac catheterization, cardiac electrophysiology, and congenital cardiac surgery, are key drivers
in their financial sustainability. Neonatal heart surgery
in particular carries a high hospital cost and collection per patient.1,65 These hospital services provide financial support at many children’s hospitals which in
turn compensates for other less lucrative but essential practices. Despite the strong financial support for
programs that offer these invasive procedures, considerable advocacy efforts remain needed. For instance, balloon septostomy for transposition of great
arteries, first performed by pediatric cardiologists in
1966, was only recently established as a billing code
with a work relative value unit (wRVU) definition. This
required efforts by multiple organizations, including the Society for Cardiovascular Angiography and
Interventions.
The ongoing COVID-
19 pandemic has impacted
all of these issues, affecting inpatient practices.
Shutdowns of elective procedures for weeks to
months depending on the location had a considerable
effect on children’s hospitals, requiring furloughs, reductions in staffing, salary cuts, or other benefit adjustments to balance finances. Even as many programs
have begun to increase elective procedures, changes
have been necessary in normal processes to ensure
the safety of the patients and staff. For instance, turnover time in procedure rooms has changed because
of the need for a certain time of air exchange after
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aerosolizing-generating procedures, extending time in
the procedure rooms and longer staff work hours.

Cardiac Surgery
During the past 60 years, the outcomes of surgery for
CHD have improved remarkably. Early technical innovations, including the Norwood procedure,66 the arterial switch operation,67 and the Fontan procedure,68
have yielded ever-
improving results consequent to
steady multidisciplinary advancements in surgery
and perioperative care.69 Despite the progress, success is not uniform and universal, and outcomes
continue to vary by surgeon, by center, and by patient.1,7,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84 Understanding
that variability, its underlying causes, and how to improve the outcome of every patient remains the primary challenge.
Cardiothoracic surgeons, through the development
of the Society of Thoracic Surgeons (STS) databases,
were early adopters of systemic outcomes monitoring,
beginning with adult cardiac surgery.85 However, the
heterogeneity of procedures performed in children and
the relative rarity of even the most common procedures
presents challenges to performance assessment. This
is different in adult cardiac surgery, in which a much
smaller variety of procedures are performed at least
an order of magnitude more frequently.86,87 Despite the
challenges, there is now a widely embraced goal of
programmatic transparency, manifested in public reporting by the STS itself, as well as various efforts at the
state level, and the “performance” ranking of centers
such as the annual US News and World Report survey.88 It should be noted that STS supports the rating
of programs (ie, with ratings of "better than expected
performance," "same as expected performance," or
"worse than expected performance").
The provision of care to patients with CHD is among
the most complex endeavors in medicine, with a well-
understood relationship between volume and quality of
care.1,89 Dilution of expertise and experience associated
with an excess number of programs is a major barrier
to improvement. This may be driven by a larger financial
incentive as often cardiac surgery programs support
several other pediatric specialties.1,65 Regionalization of
congenital cardiac care has recently been advocated
in the United States.17 It has been evaluated in pediatric cardiovascular care in a simulated manner and has
demonstrated that 67% of low-volume CHD hospitals
are within 25 miles of a larger volume CHD hospital,
suggesting that travel distances for patients could be
reasonable in a regionalized system.14 Johnson et al
published the first simulation showing that care at a
high-value center for a rare, high-risk CHD lesion may
confer significant outcome improvement and cost
savings.15 Conservative estimates suggest an overall
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reduction in operative mortality of 12% to 15%, achievable without significant reductions in patient access.90
Again, the experience of other countries may be instructive as to both the potential pitfalls and the potential benefits to children with CHD.91-93

Collaborative Knowledge Sharing
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Traditional methods of sharing advancements in medical knowledge, based on single-
center experience,
have significant limitations that have greatly inhibited
progress. To overcome these problems, multicenter
learning initiatives must be undertaken. As an example
of such a project, the National Pediatric Cardiology–
Quality Improvement Collaborative has recently initiated a “surgical coaching” project to facilitate mutual
site visits to enhance sharing of collective knowledge.
The challenges of COVID-19 may similarly benefit from
multicenter learning initiatives to establish more standardized approaches to the performance of “elective”
pediatric cardiac surgical procedures.94
Professional societies and leaders in the field are beginning to evaluate standards of care models that would
define the resources that an institution must have to perform various types of surgeries; such examples currently
exist for neonatology and pediatric surgery.95,96
Knowledge sharing has been described in quality
collaboratives with evidence of improved outcomes in
those centers involved by sharing best practices for
high-risk populations among members.11,13 A subsequent cost analysis of the effect of knowledge sharing
showed a 27% cost reduction after implementation of
the practice change suggested by the collaborative.12
Registries and databases function as repositories
of important clinical and administrative information for
various uses, including clinical, population-based epidemiologic, and outcomes research; accreditation;
education; quality improvement; advocacy; and public
reporting for administrators, care providers, advocates,
and patient and parent consumption.97-99 To be efficient, most registries are narrowly defined with a variable amount of data and data detail collected, typically
only covering a short span of time. Some databases
may be more broad based or administrative and lack
clinical depth. Unfortunately, a multiplicity of goals and
objectives have led to a plethora of databases gathering
data on the pediatric and adult congenital cardiovascular population. Most academic centers participate in
a combination of databases with rising levels of frustration because of the combined large costs and an unclear return on investment from participation. The cost
is generally not related to the initial or supplemental
costs to joining the registry or database, but attributed
to the personnel costs required to obtain the data that
will be sent to the data repository. Of course, one could
argue that the investment of this money and time and
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effort will actually save tremendous money and time
and effort by eliminating the need for expensive, time-
consuming, and labor-
intensive ad hoc exercises in
gathering data every time a new need exists for data,
whether that need is to complete a request for data
from an insurance company, governmental agency,
or hospital regulatory body. Integrating databases is a
very useful potential means of allowing multiple data
repositories to collaborate meaningfully and reduce
burden of data entry (Table 2). Such integration can
be achieved by linking databases together or by creating a single software that allows submission of data
to multiple registries with a single act of data entry. In
a health system environment that is already struggling
with cost containment, individuals and particularly
smaller programs may not have adequate resources
to participate in the large panel of repositories. The
large data harvests resulting from such efforts may be
skewed representing efforts and outcomes at several
large centers and may not be generalizable to smaller
centers. The development of high-value platforms that
address some of the issues learned from previous
registry efforts and successes requires collaboration
of multiple specialties involved in pediatric and adult
congenital cardiovascular care, including cardiovascular programs of variable types and sizes.100-106 One
way to make these data sets more robust would be to
include mechanisms to track outcomes and use them
internally as well as collaboratively for quality assurance and improvement purposes (Table 2). As a field,
our goal remains to deliver the best care in efficient
high-reliability, high-value settings and to report outcomes transparently. To do so, meticulous forethought
into integrating and streamlining databases that capture the entire course of a patient’s life course is critical
to provide the highest value care to the large, high-risk
pediatric cardiovascular population.107 It is also important that these databases be available to all institutions
and be funded at a federal/state level to provide equal
access to all participants (Table 2).
Transparency and public reporting have taken on
increasing importance as evidence suggests that outcomes are not uniform across all organizations and
vary based on center volume and physician-level factors.108-110 Currently, in the United States, there is no
central authority that mandates the number of procedures or surgeries a center must perform to be accredited in caring for patients with CHD. Outcome sharing
and transparency is an important component of the
shared decision-making process that families and physicians undergo when choosing the best treatment for
their child based on available data and on specific preferences of the family.109,111-114 Multiple challenges exist
to reliably reporting outcomes and measuring the quality of an institution, including accounting for inherent
higher risk patients who may at baseline have poorer
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outcomes. Improving public reporting will require the
creation of an easily accessible, accurate, centralized
repository that accounts for case volume, disease
complexity, and valid definition of both short-
term
and long-term outcomes (Table 2). Patient-based and
parent-based pediatric and adult congenital advocacy
groups recommended that (1) collected data points
be centralized, have standardized key variables, be
validated, and include benchmark lesions, short-term
and long-term outcomes, and patient and family experiences; (2) interpretation be risk adjusted and differentiate centers with supportive materials explaining in lay
terms how to interpret the data; and (3) presentation be
publicly reported, easily accessible, and presented by
geography/region and diagnosis. There has been a recent call to embrace regionalization of care to improve
national outcomes from pediatric cardiologists, pediatric cardiothoracic surgeons, ethicists, and patient/
parent groups.7,17,114,115 To accomplish these goals,
collaboration and engagement must be with a diverse
group of stakeholders, including physicians and other
caregivers, hospital administrative leadership, professional organizations, insurance companies, community members, families, and legislators.

Value-Based Care in CHD
Downloaded from http://ahajournals.org by on December 3, 2021

CHD management throughout a lifetime is resource
intensive, although its prevalence is quite low, with the
use of 23% of the global health resources leading to
increased health care burden.116 According to CMS,
the national health expenditure grew 4.6% to $3.8 trillion in 2019, or $11 582 per person, and accounted for
17.7% of the gross domestic product.117 The expenditure per person was found to be twice that of comparable countries.118 To address this increasing burden of
health expenditure, policies and strategies should be
employed toward containing costs that are spent on
health care services provided, insurance coverages,
public health, and research (Table 2). Lessons can be
learned from other high-
income countries that have
successfully achieved cost containment. France, the
United Kingdom, and Germany have all employed strategies that have helped contain costs. These include
public budgeting, price setting, budget cuts. They also
used a value-based approach through activity-driven
costs and use of technology assessments.119 Value-
based assessments measure outcomes that matter
to patients during the full cycle of care relative to the
costs to achieve those outcomes.120 Higher value occurs when outcomes are improved relative to the cost
to provide care for a given condition. This may occur
by improved outcomes with cost maintenance, by significantly improved outcomes at a marginally increased
cost, or by maintenance of excellent outcomes at a
lower cost. There are significant data on assessing outcomes and cost independently but not as a single value
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metric. Outcomes such as mortality, length of stay, and
prevalence of complications worsen as lesion complexity increases.1,108 Prior reports examining the relationship
between hospital volume and outcomes have shown
that mortality decreases as cardiac surgical volume increases for high-risk operations, even when adjusting
for patient-level risk factors and case mix.121 Similar to
outcome, total hospital cost varies by lesion complexity,
increasing with higher lesion complexity.1 Cost also varies widely by hospital. The variation in cost by hospital
has been investigated, and one-quarter of the variation
in cost by hospital can be explained by differences in
length of stay and complication rate.1 All of the important
data required to begin to move to value-based health
care delivery in pediatric cardiovascular care are currently in place. Data from reliable outcome registries and
administrative databases may be linked effectively to report value-based assessments transparently and publicly. These value-based assessments will significantly
impact where parents, payors, and providers seek or
refer patients for pediatric cardiovascular care.
One such important assessment of value is the
assessment of health-related quality of life (HrQOL),
which assesses various functions: physical, psychosocial, emotional, social, and school. With diagnostic
and surgical advancements, many children survive
into adulthood, therefore the assessment of HrQOL is
an important indicator of the overall health of the patient. Many HrQOL have been done on teenagers and
adults, but very few on younger children. A multicentre
prospective cross-sectional study by Abbasi et al investigated the HrQOL in children of ages 5 to 7 years,
with and without CHD. Although the perception of
HrQOL of patients with CHD was similar to health controls, the parents of patients with CHD reported a lower
HrQOL compared with parents of healthy children.122
The discrepancy in HrQOL reported by parents and
children can indicate the differences in attitudes and
perceptions toward the disease and therefore requires
family-centered approaches toward managing these
patients. Quality improvement projects are important
in assessing current practices and optimizing patient
outcomes, experiences, and values. Health care systems should therefore constantly invest in obtaining
data regarding the health and quality of life of patients
and carry out research studies to analyze these data
and ensure that a dynamic approach is used in bringing change in the provision of care based on the findings (Table 2).

THE PROVIDERS OF CARE:
WORKFORCE
Providers of care for the CHD population will also see
several changes in the coming decade as health policy
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develops. Advocacy for a diverse workforce, appropriate evaluation of provider productivity, and expanded
funding for training programs at all levels will advance
provider security and job satisfaction. Ever-specialized
advanced care providers may be necessary to augment a limited workforce as traditional delivery models
are retired.

Training the Workforce
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During the past decade, physician shortages are predicted as high as 121 000 by 2030, with projected
shortfalls in non–primary care specialties >40 000.123
This is largely cited as being attributed to physicians
entering retirement combined with an aging patient
population with greater health care needs. Despite
these predictions, pediatric cardiology has remained
a competitive subspecialty. Categorical pediatrics has
gained positions every year since 2005, with a record
high of 2864 positions offered in 2020 and a 98.2% fill
rate.124 The number of applicants to US pediatric cardiology fellowships has exceeded available positions
every year since at least 2006. This has occurred despite a steady increase in pediatric cardiology fellowship training programs from 45 programs offering 100
positions in 2006 to 59 programs offering 158 positions
in 2020.125,126 However, warning signs exist: the ratio of
applicants to available training spots has steadily decreased from a peak of 1.6:1 in 2008 to 1:1 in the most
recently completed match. This past year’s match
also saw a record 12 programs go unfilled, with 47 of
59 programs reaching their quota in the match and a
record low of 14 applicants not obtaining positions.
Applications have held steady at ≈160 to 170 per year
while training positions are increasing. It is imperative
that we envision fellowship positions as a critical component of the national—and perhaps international—
workforce and not merely a solution to local institutional
manpower demands. During the past year, fellowship
programs saw new challenges in recruitment given the
current limitations to in-person interviews. The most
recent assessment of the pediatric cardiology workforce was published in 2015, which demonstrated a
tightening in the job market with 142 jobs filled/year
from 2014 to 2015.127 The majority of 2015 survey data
respondents rated the relative ease of obtaining a job
after 3 years of core training as “somewhat difficult.”
Respondents rated obtaining jobs in interventional
cardiology and electrophysiology as the most difficult,
whereas those seeking positions in cardiac critical
care, ACHD, and heart failure/transplantation rated the
experience as “somewhat easy” to “extremely easy.”
Imaging positions were in the middle ground. The authors estimated that 135 jobs/year would be needed
subsequent to the survey, falling short of the number of
fellowship graduates per year. Furthermore, this survey
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highlights the need to better define the workforce so
that we can better meet patient needs. Perhaps the
most urgent example is growing our ACHD workforce.
Secondary to American College of Cardiology advocacy efforts, ACHD became a boarded subspecialty in
2012, and the board certification examination began in
2015. As of 2019, there are 455 board-certified ACHD
providers serving the needs of 1 to 1.3 million adult patients with CHD.128 Before 2019, this certification could
be obtained by physicians through either the training
pathway or the practice pathway. The training pathway consisted of a 2-year ACHD fellowship, and the
practice pathway consisted of physicians who were
trained in adult or pediatric cardiology without formal
training in ACHD. However, since the beginning of
2021, it is mandatory for physicians pursuing ACHD to
have a 2-year fellowship. This poses some challenges
that require physicians to revise training approaches
to meet the growing needs of ACHD care. First, there
are only 24 Accreditation Council of Graduate Medical
Education–
accredited fellowship programs across
the country. Second, there are unfilled spots in these
programs, as ACHD is not among the most interested
subspecialties.129
Therefore, a repeat pediatric cardiology workforce
assessment is essential to accurately gauge our current workforce numbers and optimize training program
numbers in both categorical and subspecialty positions. Furthermore, the infrastructure should be developed among division chiefs, private practice medical
directors, and fellowship program directors to collect
these data efficiently in an ongoing fashion to guide
the availability and curricula of fellowship programs
(Table 3).
Advanced practice providers have become key players in the pediatric cardiology workforce, particularly
Table 3. 2020 Call to Action: Advocacy Efforts in the Next
Decade That Improve the Workforce
● Align fellowship training opportunities with workforce demand
● Develop the infrastructure to rapidly obtain, analyze, and report
workforce data
● Increase efforts to diversify the workforce to better represent and
care for the populations served
● Support gender and race/ethnicity equity in career advancement
opportunities
● Enhance training programs with greater attention to issues of
health equity and the impact of racism and sexism on conscious/
unconscious bias and its impact on health care delivery
● Support the education and development of advanced practice
providers
● Enhance research funding and develop models for improved
collaboration
● Expand advocacy to address administrative issues in the workforce
○ Optimize EMRs/documentation for provider as well as
administrative satisfaction
○ Improve provider productivity definitions and academic
productivity definitions
○ Expand technology services to better serve the workforce
EMRs indicates electronic medical records.
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with the expansion of cardiac intensive care units. Of
the 112 hospitals with pediatric cardiothoracic surgery
programs in the STS database, 104 programs have
advanced practice providers in the cardiac intensive
care unit.130 However, unlike the well-defined physician
training programs, there is no standard path of training
or pediatric cardiology or cardiac intensive care unit
curriculum for advanced practice providers.130 Moving
forward, there should be clearer educational paths and
curriculum for advanced practice providers entering
the field of pediatric cardiology (Table 3).
In addition to medical workforce needs, the STS
Workforce on Congenital Heart Surgery has conducted practice surveys every 5 years to identify and
address surgical workforce needs. In addition to identifying practice information, these surveys have been
also instrumental in driving necessary approvals for
surgical therapies for our unique patient population
such as US Food and Drug Administration approval for
pediatric ventricular assist devices.131 Congenital cardiac surgery became a recognized fellowship by the
Accreditation Council of Graduate Medical Education
in 2007 with board certification offered through the
American Board of Thoracic Surgery.132 In 2020, there
were 12 applicants for 11 positions offered at 11 programs with a 91% fill rate.133 Fellows identified mentorship, rotation as a trainee, and surgery viewing as the
primary motivations to pursue a career in congenital
cardiac surgery.132 In 2015, there were 297 active congenital heart surgeons in the United States and Canada
with a 61% survey response rate to the workforce survey. Most respondents worked in a metropolitan area
(77%) with 2/3 holding academic affiliations, participating in Accreditation Council of Graduate Medical
Education accredited training, and participating in research. Although there was a trend toward higher individual case volumes compared with prior years, 51% of
respondents felt that there were too many individuals
practicing in the same geographic area. The majority
of congenital cardiac surgeons report good job satisfaction and financial stability upon retirement, with the
expected age of retirement being 67±5 years.131

The Diversity in Workforce
During the past 15 years, there has been an increase
of women entering medicine, such that most medical
students are now women. In 2016, women comprised
72.9% of pediatric residents and 50.5% of pediatric
cardiology fellows.125,127,134 Although there is an increased parity of women in training, the number of
women practicing as pediatric cardiologists was still
just 34% in 2016,134 and in adult cardiology, there is a
37% disparity in career advancement for women compared with men at similar career levels.135 Although
34% of the pediatric cardiology workforce consists of
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women, leadership positions, such as division chiefs,
are male dominated. In addition, the 2018 Doximity
Physician Compensation Report highlights a 15%
wage gap for women compared with men in pediatric
cardiology.136 This may in part be reflective of higher
proportions of men entering invasive subspecialty jobs
such as cardiac catheterization and electrophysiology or be attributed to accelerated career advancement compared with female colleagues. As part of the
ACC’s mission to improve fairness in compensation,
they have developed several compensation tools that
are freely accessible.137
Although it is an interesting question as to whether
the percentage of women in pediatric cardiology
should best mirror the gender makeup of pediatric
residents as a group or that of our patients, we face
a more significant problem with racial diversity in the
field. In 2016, the US population was 62% White,
5.2% Asian, and 31.9% underrepresented minority
groups (including Black, Hispanic, Native American,
and Pacific Islander), and the latter group represented
only 16% of pediatric residents.134 Underrepresented
minority groups comprise an even smaller percentage
of pediatric cardiology, with a slight increase among
fellows from 7.7% in 2006 to 9.9% in 2016 and a similar
increase in practicing pediatric cardiologists from 5.8%
to 7.8%.134 Furthermore, the ethnic diversity of faculty
is almost nonexistent at the leadership level in pediatric
cardiology.
Beyond this, retaining women and pediatric cardiologists of different ethnicities in academic heart centers
is also of critical importance. Mounting evidence suggests that when physicians and patients share the same
race or ethnicity, this improves medication adherence,
shared decision-making, patient retention, and patient
perceptions of treatment decisions. Not surprisingly, implicit bias from the physician has decreased.
Women currently comprise 5% of practicing congenital cardiothoracic surgeons but represent 20%
of cardiothoracic surgery residents.138 Women report
similar career satisfaction to men but are less likely to
perform research during their careers and less likely to
be married or have children.135 The majority of female
and Black patients reported explicit bias within the cardiothoracic surgical community in a recent survey of
the members of the STS.139 Women also have more
difficulty in retention and promotion than their male
colleagues.138 This is especially pronounced in Black
female surgeons, with <8% of these academic surgeons holding the role of full professor.140 Mentorship
in Surgery programs has been cited as an essential
component to advancement for women and those
belonging to vulnerable ethnic groups.141 In a survey
seeking to explore ways to improve diversity and inclusion within the STS, the need for both culture change
and mentorship emerged as critical areas.
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Studies have shown that increased diversity leads
to improved critical thinking142 and improved scientific research products.143 In the business sector, the
highest yield for increasing diversity has been college
recruitment efforts and dedicated mentorship programs.144 We must strategize ways to increase interest
in pediatric cardiology among medical students and
residents of all ethnicities. This may be achieved by
early exposure during training; loan forgiveness, particularly for the lengthy training required in pediatric
cardiology subspecialties; and allotted research time
aimed toward research efforts.143 In addition, making
sure that institutional, regional, and national CHD initiatives and policy statements prioritize health equity and
include distinct leadership roles for underrepresented
minority trainees and faculty who undoubtedly bring a
different perspective to the table than the status quo.
We must continue to strive for expanded diversity in
the field for all of these reasons so that our workforce
reflects the population it serves (Table 3).

Assessment of Provider Productivity

Downloaded from http://ahajournals.org by on December 3, 2021

Physician productivity can be difficult to measure. If focused on purely clinical work, the wRVU system is most
commonly used to assess the amount of work done in a
particular specialty.145 The wRVUs do not always reflect
the time and effort spent with complex patients in the
outpatient space. This is particularly challenging while
evaluating ACHD. Notably, wRVUs will differ considerably across specialties and between procedural and
nonprocedural visits. For instance, a pediatric transplant
cardiologist has very few billable codes outside of clinic
visits—for this specialty, use of a wRVU system will be
ineffective. These issues become important in the calculation of salaries for the practitioners involved. In the
Merritt Hawkins 2019 review of physician-recruiting incentives, 70% to 75% of physicians were paid a base
salary with some form of bonus.146 The metric to obtain a
bonus was based on wRVUs in 70% of these cases. The
base salaries themselves are commonly derived from
published data from the Association of Administrators in
Academic Pediatrics, Association of American Medical
Colleges, or Medical Group Management Association
models. Academic rank commonly plays a large role in
the salaries as well, depending on the institution. It is important to note that in a pediatric cardiology group with
all subspecialists, it is critical to have breadth and depth
in all areas, independent of wRVUs. For example, optimal
and outstanding care requires general pediatric cardiologists who provide outpatient care, generally associated
with lower wRVUs, as well as interventional cardiologists,
who tend to generate a greater wRVU load.
Productivity measures will be exceedingly difficult
to assess this year; for instance, if a pediatric cardiologist is pulled to cover adult intensive care unit care
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for patients with COVID-19, how does that time count
against their wRVU goals? With fewer surgeries and
procedures, can any “normal” goals be used at any
institution? Because of financial pressures, many organizations have had to place holds on hiring, with delays
in training and academic advancement also expected.
In light of these COVID-19–related issues, it is likely that
some changes in the way wRVUs are assessed will be
needed in the field. Assessments of quality and timeliness of care could be considered as a part of a new
model, which will need to be flexible enough to account for the ongoing, undulating course of the current
pandemic (Table 3).
Involvement in research and teaching are imperative to physicians and require time and effort. However,
as there is often no objective way to measure one’s involvement in research and teaching other than a number of publications and grants, these contributions are
often undermined.147 The RVU, therefore, can be used
to assess academic productivity, which includes research and teaching. However, its application and calculation can be tedious as there are multiple forms of
teaching, and equating the time and effort put in these
can be difficult. For example, how can giving an hour-
long presentation to 200 students and residents at a
grand round be equated to providing a 40-hour weekly
bedside clinical teaching session to 5 students? It is
these challenges that have led different academic institutions and departments to adopt different metrics
for RVUs, which leads to inconsistencies in assessment. Despite these challenges, Mezrich and Nagy
developed a web-based academic RVU system that
assigned weights to different elements of academic
activities so as to develop an academic RVU for administrative work and community services, research,
and teaching.148 Although these weights are arbitrary,
if applied to all physicians equally, they can generate
meaningful results reflecting academic productivity.148 It is evident that RVUs can provide an objective
method of calculating work contributed by the physicians, and therefore programs must employ careful
weights to every activity to ensure appropriate calculations (Table 3).

Role of Patient–Family Centered
Organizations in Advocating for Patients
With CHD
The Congenital Heart Public Health Consortium, formed
in 2009, is an organization that maintains public–private
partnership consisting of all stakeholders involved in
the care of children with heart disease and strives to
contribute to bring change in the lives of these children through advocacy and public health initiatives.149
The consortium consists of 200 individual and organization members, including academic and parent-
led
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organizations and federal agency representatives. In
addition to coming together in the consortium, these
patient-centered and family-centered organizations are
catalysts in advocating for children with CHD as they
are passion and mission driven. Implementing solutions
is an important responsibility, and these organizations
can collaborate with health care providers and facilities
to help implement solutions.2 One of the issues identified in this article and other literature is the barriers to
lifelong care for children with CHD and the management of other comorbidities. These organizations can
help create awareness in the families, on individual
and population levels, to ensure that they recognize
the need for multidisciplinary and lifelong care. This includes early identification of neurodevelopmental disabilities and timely intervention (Table 1). Another area
of contribution can be creating awareness of the importance of transition of care to ACHD services.
In addition, these organizations can be key players
in putting their efforts in prevention of CHD. Gestational
diabetes and infectious diseases are important risk
factors for CHD, and therefore appropriate screening
of gestational diabetes, timely fetal echocardiograms,
and education of women about the management of
these diseases can help reduce the incidence of CHD
among newborns. This will require close collaboration
with the obstetrics and gynecology departments.

decreasing barriers and stress, and increasing diversity will be important issues during the next 10 years. It
is only with the consolidated efforts of our community
of providers, families, patients, and all advocates that
we will make an impact.

2020 TO 2030 VISION

Disclosures

As we enter the next decade, the field of CHD care
has an obligation to review the lessons of the prior
decade and lead the charge on forward looking to
patient-centered, value-based care for our patients.
Issues related to health care policy in patients with
CHD become a focus for the many stakeholders involved. CHD will continue as the most common cause
of birth defects and a leading cause of morbidity and
mortality and resource use. During the past couple of
years, there has been significant but limited progress
in aspects of health care policy as evidenced by recent
legislation demonstrating effective advocacy. For progress, continued work will be needed to build on these
improvements, particularly as we evaluate issues that
were exposed during the COVID-19 pandemic.
Moving forward, the focus of our efforts in the next
decade should encompass the issues laid out in this
article. Importantly, all stakeholders should be involved
in creating goals and policy. The patients with CHD
themselves and their families will continue to be important drivers of this advocacy agenda. Most of the
efforts outlined revolve around access to care, affordability, and accessibility for all populations. In addition, leaders will continue to focus on issues related
to the delivery of services and identification for areas
of improvement. Finally, training the future workforce,
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